Event Detail (Archived)

Lipid Nanoparticles Enabled mRNA Therapeutics

  • This event already took place in March 2026
  • 116 Rockefeller Research Laboratories, MSKCC, 430 E. 67th St.

Event Details

Type
Cancer Engineering Seminar Series
Speaker(s)
Yizhou Dong, Ph.D., Mount Sinai Endowed Professor, Icahn School of Medicine at Mount Sinai
Open to
Public
Reception
Tea, 3:45 p.m.
Phone
(646) 888-3712
Sponsor
Beneysha Bolden
(646) 888-3712
boldenb@mskcc.org

Related News

Symposium highlights SNFiRU's transition from incubator to engine

Three years in, the Stavros Niarchos Foundation Institute for Global Infectious Disease Research has matured into a working pipeline connecting basic science and emerging therapies.

A new mouse model of virus-driven liver cancer may open the door to better diagnosis and treatments

Researchers created the first mouse model in which chronic viral infection progresses to liver cancer, closely mirroring what happens in people with hepatitis C.

Three Rockefeller researchers chosen for the Biohub NY Immune Cell Reprogramming Program

The Rockefeller teams will map immune cell interactions, engineer cells as drug delivery systems, and activate immune responses in hard-to-treat cancers.

Related Events

Improving Genomic Deep Learning with Perturbation Data

| ZUCKERMAN AUDITORIUM, MSKCC, 417 E. 68TH ST.

Cell Biology Course

| CARSON FAMILY AUDITORIUM (CRC)
Spatial control of protein degradation

BioStudies Database: A Resource For Sharing And Publishing Life Sciences Data

| WEBINAR